HAIFA, Israel – September 13 2022 – GrayMatters Health (GMH), developer of digital self-neuromodulation therapeutics for mental disorders, announced today that it has been named as a Falling Walls Top 25 Venture winner. The award recognizes the most promising science start-ups and innovations and technologies across their respective industries.
As one of the…
HAIFA, Israel – September 7, 2022 – GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental disorders, has been awarded a €2.5 million grant from the European Innovation Council (EIC) to accelerate the development of Prism for PTSD, a non-invasive digital therapy, to be used as an adjunct to standard of care (SOC) treatments…
Investment Led by Otsuka Medical Devices
HAIFA, Israel, Jan. 11, 2022 /PRNewswire/ -- GrayMatters Health (GMH) developer of digital self-neuromodulation therapeutics for mental disorders, announced today the successful closing of its $10 million Series A financing round. Otsuka Medical Devices Co., Ltd. (OMD) was the lead investor in this round. In addition to its investment, OMD obtained certain rights with regard…
HAIFA, Israel – December 21, 2021 – GrayMatters Health (GMH), developer of digital self-neuromodulation therapeutics for mental disorders, announced today that the Red Herring judging panel has included GMH in its Top 100 Europe award list, which recognizes Europe’s leading private companies and celebrates these startups’ innovations and technologies across their respective industries.
“We are…
Represents the first attempt to deliver a mental health therapy for depression based on a biological marker as adjunct to standard of care
PRESS RELEASE PR Newswire Jul. 13, 2021, 09:00 AM
HAIFA, Israel, July 13, 2021 /PRNewswire/ -- GrayMatters Health, a digital therapeutics start-up company, recently announced its latest success in winning a series of international awards for its groundbreaking medical technology which implements self-neuromodulation of amygdala-fMRI inspired EEG model for the treatment of mental disorders such as PTSD.
The company's most recent accomplishment was being chosen as one of the top eight…
Science-based university spinoff companies are to present their technology and their business plans in the final rounds of The Spinoff Prize, a Nature Research Award supported by Merck KGaA, Darmstadt, Germany that aims to support and give visibility to academic entrepreneurs and their companies.
London | New York | Darmstadt, 24 June 2021
Nature Research…
Consortium of Life Science and Healthcare Leaders Identify Disruptive Digital Health Solutions to Mitigate the Global Mental Health Crisis
New York, NY – Today, the HITLAB Breakthrough Alliance (BTA) announced its final selection of a digital health innovation for rapid verification testing of their new solution by HITLAB. The selected innovators – GrayMatters Health Ltd. – were chosen from a…
We are proud to present the Israeli winners of the 2021 SelectUSA Tech pitching sessions! SelectUSA Tech #startups from around the world competed across 9 pitching sessions. Over 200 companies applied for a spot in one of nine industry pitching sessions.
The judging panels were impressed with the quality of pitches companies delivered. SelectUSA commends participants on their presentations.…